As expected, we found that overexpression of HACE1 in glioma cells substantially enhanced the ability of cell proliferation and invasiveness compared with the control, and these effects were effectively attenuated upon NRF2 knockdown (Supplementary Fig. S8). Here, HACE1 is linked to central nervous system cancer.